Investor Relations

CORPORATE PROFILE

Pulse Biosciences, Inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary Nano-Pulse Stimulation (NPS) technology. NPS is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. These cell effects influence cell regulation functions and can lead to unique immune system responses. Pulse Biosciences is investigating a variety of applications for its NPS technology that exploits its unique biologic effect, including immuno-oncology and dermatology.

STOCK QUOTE

Copyright Nasdaq. Minimum 15 minutes delayed.

STOCK CHART